Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

INSP

Inspire Medical Systems Inc

Feb 13 • 04:00PM ET

59.76

+0.11 0.18 %

Healthcare • Medical Devices • USA • NYSE

Feb 13, 1:35 PMWolfe Research downgraded Inspire Medical Systems to Peer Perform, citing Medicare reimbursement reversals that remove expected pricing tailwinds and increase uncertainty around the company’s guidance and earnings outlook.

Peers: MDT SYK EW TFX ZBH BSX PEN IART GMED CNMD

| Held by: IJR VTI VB VBK VXF SPSM IJT IWP VIOO VHT

Index	-	P/E	12.04	EPS (ttm)	4.96	Insider Own	4.48%	Shs Outstand	28.58M	Perf Week	-9.04%
Market Cap	1.74B	Forward P/E	22.34	EPS next Y	2.68	Insider Trans	-1.09%	Shs Float	27.76M	Perf Month	-35.78%
Enterprise Value	1.46B	PEG	1.72	EPS next Q	-0.26	Inst Own	112.32%	Short Float	13.94%	Perf Quarter	-34.26%
Income	145.42M	P/S	1.90	EPS this Y	-19.40%	Inst Trans	-17.21%	Short Ratio	2.37	Perf Half Y	-29.34%
Sales	911.98M	P/B	2.19	EPS next Y	37.17%	ROA	16.84%	Short Interest	3.87M	Perf YTD	-35.21%
Book/sh	27.33	P/C	5.63	EPS next 5Y	12.95%	ROE	19.77%	52W High	197.75 -69.78%	Perf Year	-68.07%
Cash/sh	10.61	P/FCF	22.13	EPS past 3/5Y	- -	ROIC	17.93%	52W Low	53.11 12.52%	Perf 3Y	-77.95%
Dividend Est.	-	EV/EBITDA	22.50	Sales past 3/5Y	30.77% 51.21%	Gross Margin	85.39%	Volatility	8.60% 6.82%	Perf 5Y	-74.81%
Dividend TTM	-	EV/Sales	1.60	EPS Y/Y TTM	180.19%	Oper. Margin	5.59%	ATR (14)	5.39	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.56	Sales Y/Y TTM	13.60%	Profit Margin	15.95%	RSI (14)	23.31	Recom	2.37
Dividend Gr. 3/5Y	- -	Current Ratio	6.08	EPS Q/Q	306.12%	SMA20	-20.83%	Beta	0.77	Target Price	82.33
Payout	0.00%	Debt/Eq	0.04	Sales Q/Q	12.25%	SMA50	-37.45%	Rel Volume	1.15	Prev Close	59.65
Employees	1333	LT Debt/Eq	0.04	Earnings	Feb 11 AMC	SMA200	-43.20%	Avg Volume	1.63M	Price	59.76
IPO	May 03, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	122.43% 1.28%	Trades		Volume	1,885,556	Change	0.18%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-13-26	Downgrade	Wolfe Research	Outperform → Peer Perform
Feb-12-26	Downgrade	Wells Fargo	Overweight → Equal Weight	$70
Feb-12-26	Downgrade	Robert W. Baird	Outperform → Neutral	$74
Jan-27-26	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$90
Jan-22-26	Downgrade	Truist	Buy → Hold	$96
Jan-22-26	Downgrade	Oppenheimer	Outperform → Perform
Dec-08-25	Upgrade	Oppenheimer	Perform → Outperform	$175
Dec-02-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$130
Nov-26-25	Upgrade	Truist	Hold → Buy	$165
Nov-25-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$180
Nov-24-25	Upgrade	Stifel	Hold → Buy
Nov-04-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$90
Oct-24-25	Downgrade	Jefferies	Buy → Hold	$85
Sep-22-25	Downgrade	UBS	Buy → Neutral	$89
Sep-02-25	Initiated	Evercore ISI	Outperform	$150
Aug-05-25	Downgrade	Truist	Buy → Hold	$125
Aug-05-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Aug-05-25	Downgrade	JP Morgan	Overweight → Neutral	$110
Nov-20-24	Upgrade	BofA Securities	Neutral → Buy	$220 → $255
May-08-24	Downgrade	BofA Securities	Buy → Neutral	$265 → $225

Show Previous Ratings

Feb-13-26 01:23PM	Wolfe downgrades Inspire Medical on Medicare payment reversal (Investing.com)
Feb-12-26 08:06PM	Inspire Medical Systems Inc (INSP) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com) -12.55%
11:55AM	Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why (StockStory)
10:54AM	INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands (Zacks)
09:44AM	Shopify upgraded, Coinbase downgraded: Wall Street's top analyst calls (The Fly)
12:32AM	Loading…
12:32AM	INSP Q4 Deep Dive: Reimbursement Uncertainty Shapes Outlook Despite Strong Product Adoption (StockStory)
Feb-11-26 08:39PM	Inspire Medical Systems Q4 Earnings Call Highlights (MarketBeat)
08:04PM	Inspire Medical Systems, Inc. Q4 2025 Earnings Call Summary (Moby)
05:15PM	Inspire Medical Systems (INSP) Beats Q4 Earnings and Revenue Estimates (Zacks)
04:30PM	Inspire: Q4 Earnings Snapshot (Associated Press Finance)
04:26PM	Inspire Medical Systems (NYSE:INSP) Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops (StockStory)
04:02PM	Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-10-26 09:15AM	Inspire (INSP) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Feb-09-26 10:04PM	Inspire Medical Systems (INSP) Q4 Earnings: What To Expect (StockStory)
Feb-05-26 10:00AM	10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
08:55AM	Loading…
08:55AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Feb-04-26 10:00AM	Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) -5.37%
Feb-03-26 08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Jan-28-26 10:33PM	Unpacking Q3 Earnings: Inspire Medical Systems (NYSE:INSP) In The Context Of Other Medical Devices & Supplies - Specialty Stocks (StockStory)
Jan-22-26 03:06PM	Russell 2000 Extends Records, Meta Jumps 5%: What's Moving Markets Thursday? (Benzinga) -16.00%
02:21PM	Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why (StockStory)
12:32PM	Here's Why You Should Retain INSP Stock in Your Portfolio for Now (Zacks)
03:18AM	Wells Fargo Is Bullish on Inspire Medical Systems, Inc. (INSP) Despite Short-Term Reimbursement Concerns (Insider Monkey)
Jan-20-26 11:05PM	2 Reasons to Watch INSP and 1 to Stay Cautious (StockStory)
Jan-15-26 03:01PM	Inspire Medical Systems, Inc. (INSP): A Bull Case Theory (Insider Monkey)
Jan-13-26 11:22AM	JPM26: Inspire Medical Systems projects a strong 2026 (Medical Device Network)
05:00AM	Inspire appoints Matt Osberg as CFO (MedTech Dive)
Jan-12-26 06:45AM	Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance (GlobeNewswire)
Jan-07-26 08:00AM	Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 (GlobeNewswire)
07:33AM	TEM's Stable Solvency and Financial Strength Are Gaining Attention (Zacks)
07:57AM	Loading…
Jan-06-26 07:57AM	Inspire Medical Systems (INSP) Hit by Execution Difficulties in Q3 (Insider Monkey)
Jan-02-26 09:00AM	Investors in Inspire Medical Systems, Inc. Should Contact Levi & Korsinsky Before January 5, 2026 to Discuss Your Rights - INSP (PR Newswire)
Dec-29-25 08:00AM	Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
04:01AM	Inspire Medical Systems, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INSP (PR Newswire)
Dec-22-25 07:51AM	Here's Why You Should Retain INSP Stock in Your Portfolio Now (Zacks)
Dec-18-25 03:15PM	Why Inspire Medical Systems (INSP) Shares Are Sliding Today (StockStory) -19.45%
Dec-17-25 04:07PM	Inspire Medical (INSP) Crashes Over 32%, "Inspire V" Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5 (PR Newswire)
01:00PM	Inspire Medical Systems (INSP) Stock Is Up, What You Need To Know (StockStory)
Dec-16-25 09:00AM	Investors in Inspire Medical Systems, Inc. Should Contact Levi & Korsinsky Before January 5, 2026 to Discuss Your Rights - INSP (PR Newswire)
Dec-15-25 09:08AM	Inspire Medical Systems (INSP) Fell Following Reduced Full-Year Guidance (Insider Monkey) -8.74%
Dec-11-25 08:04AM	Inspire Medical (INSP) Fell Due to Multiple Headwinds (Insider Monkey)
07:49AM	Inspire Medical Systems, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INSP (PR Newswire)
Dec-10-25 01:05PM	Why Inspire Medical Systems (INSP) Stock Is Up Today (StockStory)
Dec-09-25 12:58PM	Inspire Medical (INSP) Crashes Over 32%, "Inspire V" Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5 (PR Newswire)
Dec-08-25 04:01PM	Shareholders who lost money in shares of Inspire Medical Systems, Inc. (NYSE: INSP) Should Contact Wolf Haldenstein Immediately (PR Newswire) +5.25%
11:51AM	Inspire Medical Systems (INSP) Stock Trades Up, Here Is Why (StockStory)
Dec-04-25 11:30AM	Why Is Tempus (TEM) Down 8.9% Since Last Earnings Report? (Zacks)
Dec-03-25 02:52PM	Inspire Medical (INSP) Crashes Over 32%, "Inspire V" Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5 (PR Newswire)
11:30AM	Why Is Inspire (INSP) Up 57.6% Since Last Earnings Report? (Zacks)
07:45AM	Inspire Medical Systems, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights INSP (Business Wire)
Dec-02-25 11:11AM	Why Inspire Medical Systems (INSP) Stock Is Trading Up Today (StockStory) +6.01%
09:34AM	Teradyne upgraded, Circle Internet initiated: Wall Street's top analyst calls (The Fly)
09:00AM	Inspire Medical Systems, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - INSP (PR Newswire)
Dec-01-25 03:18PM	INSP SHAREHOLDERS: Inspire Medical Systems, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by January 5 (Newsfile)
Nov-26-25 04:25PM	Did You Lose Money in Inspire Medical Systems, Inc.? Contact Robbins LLP for Information About Recovering Your Losses (PR Newswire)
08:38AM	Inspire Medical (INSP) Jumps to 3-Month High on Bullish Coverage, PT Upgrade (Insider Monkey)
Nov-25-25 04:20PM	Inspire Medical (INSP) Sued Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman (PR Newswire) +11.17%
01:01PM	Inspire Medical Systems (INSP) Shares Skyrocket, What You Need To Know (StockStory)
09:36AM	Brinker upgraded, Coinbase downgraded: Wall Street's top analyst calls (The Fly)
06:12AM	S&P Futures Tick Lower With Focus on U.S. Retail Sales and PPI Data (Barchart)
Nov-24-25 02:06PM	Alphabet stock pops on Gemini 3 rollout, Inspire Medical surges (Yahoo Finance Video) +30.51%
12:40PM	Inspire Medical Systems (INSP) Shares Skyrocket, What You Need To Know (StockStory)
09:50AM	Inspire Medical Stock Is Down 41% This Year. Why It's Surging Today. (Barrons.com)
Nov-20-25 01:28PM	Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman (Newsfile)
05:45AM	1 Safe-and-Steady Stock to Own for Decades and 2 We Question (StockStory)
Nov-18-25 11:03AM	Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman (PR Newswire)
08:00AM	Inspire Medical Systems, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
07:33AM	Artisan Small Cap Fund Sold Inspire Medical Systems (INSP) Amid Challenges (Insider Monkey)
Nov-15-25 04:46AM	Are Options Traders Betting on a Big Move in INSP Stock? (Zacks)
Nov-13-25 09:05AM	Investors Urged to Contact Levi & Korsinsky for Information Before January 5, 2026 - Inspire Medical Systems, Inc. (INSP) (Newsfile)
09:00AM	Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman (Business Wire)
08:25AM	Shareholders who lost money in shares of Inspire Medical Systems, Inc. (NYSE: INSP) Should Contact Wolf Haldenstein Immediately (PR Newswire)
Nov-11-25 03:55PM	Inspire Medical Systems, UFP Technologies, Astrana Health, Option Care Health, and The Pennant Group Shares Skyrocket, What You Need To Know (StockStory) +5.25%
Nov-10-25 09:00AM	Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman (PR Newswire) +5.23%
12:32AM	The Top 5 Analyst Questions From Inspire Medical Systems's Q3 Earnings Call (StockStory)
Nov-08-25 11:04AM	Important Notice to Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office Is Investigating Claims on Your Behalf (Newsfile)
Nov-04-25 01:05PM	Why Inspire Medical Systems (INSP) Stock Is Trading Up Today (StockStory) +15.33%
12:52PM	INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Expands (Zacks)
09:35AM	DraftKings, Flutter downgraded: Wall Street's top analyst calls (The Fly)
08:41AM	INSP Q3 Deep Dive: Inspire V Launch Drives Adoption, Margin Pressures Persist (StockStory)
12:03AM	Inspire Medical Systems Inc (INSP) Q3 2025 Earnings Call Highlights: Revenue Growth and ... (GuruFocus.com)
Nov-03-25 06:30PM	Inspire (INSP) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:35PM	Inspire Medical Systems (INSP) Tops Q3 Earnings and Revenue Estimates (Zacks)
04:36PM	Inspire: Q3 Earnings Snapshot (Associated Press Finance)
04:17PM	Inspire Medical Systems (NYSE:INSP) Posts Better-Than-Expected Sales In Q3 (StockStory)
04:02PM	Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook (GlobeNewswire)
Nov-01-25 11:03PM	Inspire Medical Systems (INSP) Reports Earnings Tomorrow: What To Expect (StockStory)
Oct-31-25 09:21AM	Inspire Medical Systems Inc (INSP) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-30-25 07:52AM	Inspire Medical Systems (INSP) Dropped After Lowering Its Financial Guidance (Insider Monkey)
Oct-29-25 01:39PM	Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings? (Zacks)
10:00AM	Senseonics Holdings (SENS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Oct-28-25 08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
Oct-27-25 08:00AM	Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference (GlobeNewswire)
Oct-24-25 02:36PM	Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why (StockStory)
09:34AM	Coinbase, eBay upgraded: Wall Street's top analyst calls (The Fly)
Oct-22-25 12:03AM	3 Reasons INSP Has Explosive Upside Potential (StockStory)
Oct-21-25 01:43PM	Inspire Medical Systems (INSP) Shows Improved Sleep Apnea Outcomes with Inspire V System (Insider Monkey)
Oct-20-25 06:31AM	nspire Medical Systems (INSP) Shows Improved Sleep Apnea Outcomes with Inspire V System (Insider Monkey)
Oct-14-25 09:59AM	Here's What Happened to Inspire Medical (INSP) in Q3 (Insider Monkey)
Oct-13-25 04:41PM	Why Inspire Medical Systems (INSP) Stock Is Up Today (StockStory)

Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rondoni John	See Remarks	Jan 09 '26	Sale	100.00	109	10,900	13,797	Jan 12 04:05 PM
JOHN RONDONI	Officer	Jan 09 '26	Proposed Sale	95.00	109	10,355		Jan 09 04:32 PM
mcCormick Shawn	Director	Dec 02 '25	Sale	139.00	1,200	166,800	24,846	Dec 04 04:05 PM
SHAWN T MCCORMICK	Director	Dec 02 '25	Proposed Sale	126.34	1,200	151,608		Dec 02 04:27 PM
mcCormick Shawn	Director	Nov 28 '25	Sale	127.48	2,000	254,960	26,046	Dec 01 05:56 PM
SHAWN T MCCORMICK	Director	Nov 28 '25	Proposed Sale	127.33	2,000	254,660		Nov 28 01:16 PM
Curet Myriam	Director	Mar 20 '25	Buy	163.84	4	655	3,370	Nov 24 08:40 PM
Curet Myriam	Director	Apr 07 '25	Buy	148.26	1	148	3,371	Nov 24 08:40 PM
Curet Myriam	Director	Aug 08 '25	Sale	77.28	4	309	3,365	Nov 24 08:40 PM
Curet Myriam	Director	May 08 '25	Sale	153.22	2	306	3,369	Nov 24 08:40 PM
Buchholz Richard	Chief Financial Officer	Aug 29 '25	Sale	93.39	11,000	1,027,290	44,867	Sep 02 08:14 PM
Buchholz Richard	Officer	Aug 29 '25	Proposed Sale	93.40	11,000	1,027,349		Aug 29 04:49 PM
Buchholz Richard	Chief Financial Officer	Aug 19 '25	Option Exercise	62.74	25,008	1,569,031	61,247	Aug 21 04:05 PM
mcCormick Shawn	Director	Jun 04 '25	Option Exercise	16.00	4,000	64,000	28,046	Jun 06 06:06 PM
Rondoni John	See Remarks	May 19 '25	Sale	149.38	1,734	259,025	13,766	May 21 04:05 PM
JOHN RONDONI	Officer	May 19 '25	Proposed Sale	149.38	1,734	259,025		May 19 04:01 PM
mcCormick Shawn	Director	May 02 '25	Sale	160.00	360	57,600	24,046	May 05 07:31 PM
SHAWN T MCCORMICK	Director	May 02 '25	Proposed Sale	157.90	360	56,844		May 02 04:23 PM
Ban Randy	See Remarks	Mar 03 '25	Sale	185.84	3,947	733,496	7,259	Mar 05 04:47 PM
Rondoni John	Chief Technology Officer	Mar 03 '25	Sale	185.60	2,287	424,467	15,500	Mar 05 04:46 PM
JOHN RONDONI	Officer	Mar 03 '25	Proposed Sale	185.60	2,287	424,467		Mar 03 04:27 PM
RANDALL BAN	Officer	Feb 28 '25	Proposed Sale	184.02	3,947	726,327		Feb 28 04:18 PM

Open in Screener

LUNG

Pulmonx Corp

Feb 13 • 04:00PM ET

1.47

+0.05 3.52 %

Healthcare • Medical Devices • USA • NASD

Peers: DHR MDT EW ISRG SYK BSX ZBH HOLX XRAY ALGN

| Held by: VTI IWM VXF IWO VTWO IWC ITOT VTWG RSSL IWV

Index	RUT	P/E	-	EPS (ttm)	-1.41	Insider Own	13.10%	Shs Outstand	41.25M	Perf Week	-2.00%
Market Cap	60.63M	Forward P/E	-	EPS next Y	-1.34	Insider Trans	-1.51%	Shs Float	35.84M	Perf Month	-26.50%
Enterprise Value	40.38M	PEG	-	EPS next Q	-0.39	Inst Own	81.04%	Short Float	7.86%	Perf Quarter	-25.00%
Income	-56.75M	P/S	0.66	EPS this Y	-1.62%	Inst Trans	-8.41%	Short Ratio	4.09	Perf Half Y	-2.65%
Sales	91.66M	P/B	1.01	EPS next Y	8.66%	ROA	-37.13%	Short Interest	2.82M	Perf YTD	-33.48%
Book/sh	1.46	P/C	0.79	EPS next 5Y	14.12%	ROE	-73.73%	52W High	9.37 -84.31%	Perf Year	-80.08%
Cash/sh	1.86	P/FCF	-	EPS past 3/5Y	-2.30% -19.80%	ROIC	-49.20%	52W Low	1.31 12.21%	Perf 3Y	-83.54%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.06% 20.78%	Gross Margin	73.08%	Volatility	7.09% 6.57%	Perf 5Y	-97.53%
Dividend TTM	-	EV/Sales	0.44	EPS Y/Y TTM	4.13%	Oper. Margin	-62.38%	ATR (14)	0.11	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.15	Sales Y/Y TTM	15.59%	Profit Margin	-61.91%	RSI (14)	33.81	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	4.86	EPS Q/Q	5.33%	SMA20	-10.31%	Beta	0.09	Target Price	5.75
Payout	-	Debt/Eq	0.94	Sales Q/Q	5.47%	SMA50	-26.64%	Rel Volume	0.36	Prev Close	1.42
Employees	291	LT Debt/Eq	0.92	Earnings	Nov 12 AMC	SMA200	-33.54%	Avg Volume	688.58K	Price	1.47
IPO	Oct 01, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	19.43% 2.49%	Trades		Volume	250,579	Change	3.52%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-25	Downgrade	Piper Sandler	Overweight → Neutral	$2.50
Mar-10-25	Initiated	D. Boral Capital	Buy	$17
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$17 → $7.50
Jun-04-24	Initiated	Lake Street	Buy	$12
Feb-23-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$16 → $14
Sep-05-23	Initiated	Craig Hallum	Buy	$18
Feb-27-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$10 → $15
Jan-03-23	Downgrade	BofA Securities	Neutral → Underperform	$8
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$14 → $10
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$23 → $19
Mar-02-22	Resumed	BofA Securities	Neutral	$28
Dec-08-21	Upgrade	Piper Sandler	Neutral → Overweight	$45
Apr-01-21	Initiated	Citigroup	Buy	$60
Mar-25-21	Initiated	Piper Sandler	Neutral	$50
Mar-10-21	Upgrade	BofA Securities	Neutral → Buy	$72
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Oct-26-20	Initiated	Wells Fargo	Equal Weight	$46
Oct-26-20	Initiated	Stifel	Buy	$50
Oct-26-20	Initiated	Morgan Stanley	Equal-Weight	$44
Oct-26-20	Initiated	Canaccord Genuity	Buy	$49

Show Previous Ratings

Dec-03-25 04:05PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +8.00% +13.23%
Nov-13-25 12:01AM	Pulmonx Corp (LUNG) Q3 2025 Earnings Call Highlights: Navigating Growth Challenges and ... (GuruFocus.com) -18.88%
Nov-12-25 05:30PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -6.22%
04:05PM	Pulmonx Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 07:15PM	American Well Corporation (AMWL) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -6.01%
05:43AM	Loading…
Oct-31-25 05:43AM	Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? (Insider Monkey) +13.64%
Oct-28-25 10:03AM	Pulmonx Corp (LUNG) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com) +26.92%
Oct-27-25 04:05PM	Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025 (GlobeNewswire)
Oct-15-25 04:05PM	Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025 (GlobeNewswire)
Aug-27-25 12:00PM	What Makes Pulmonx (LUNG) a New Buy Stock (Zacks) +5.08%
Aug-26-25 04:05PM	Pulmonx to Participate in September Investor Conferences (GlobeNewswire) +5.99%
Aug-11-25 05:00AM	Apreo raises $130M for pivotal trial of emphysema device (MedTech Dive)
Aug-05-25 09:35AM	After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG) (Zacks)
Jul-31-25 03:33AM	Pulmonx Corp (LUNG) Q2 2025 Earnings Call Highlights: Strong International Growth Amid US Challenges (GuruFocus.com) -41.59%
Jul-30-25 06:00PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Loading…
04:05PM	Pulmonx Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-29-25 04:05PM	Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
10:05AM	Pulmonx Corp (LUNG) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-16-25 04:05PM	Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025 (GlobeNewswire) +7.78% +6.19%
May-28-25 04:05PM	Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire) +8.11%
May-03-25 11:00AM	Ford, Disney, And AMD To Report Results Next Week (Seeking Alpha)
May-01-25 04:05PM	Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference (GlobeNewswire) -21.95%
10:06AM	Q1 2025 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
03:18AM	Pulmonx Corp (LUNG) Q1 2025 Earnings Call Highlights: Strong International Growth Amid Domestic ... (GuruFocus.com)
Apr-30-25 08:25PM	Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript (Seeking Alpha) -8.35%
06:10PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-16-25 04:05PM	Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025 (GlobeNewswire) -5.64%
06:53AM	P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar? (Zacks)
Apr-10-25 11:38AM	Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? (Zacks)
01:14PM	Loading…
Feb-20-25 01:14PM	Q4 2024 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents) +32.23%
02:12AM	Pulmonx Corp (LUNG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Financial ... (GuruFocus.com)
Feb-19-25 05:20PM	Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -5.01%
04:05PM	Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
04:58AM	What To Expect From Pulmonx Corp (LUNG) Q4 2024 Earnings (GuruFocus.com)
Feb-13-25 04:05PM	Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day (GlobeNewswire) +5.28% -5.56%
Feb-05-25 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 (GlobeNewswire) +6.59%
Nov-21-24 09:55AM	Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect? (Zacks)
Nov-20-24 04:05PM	Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-19-24 09:00AM	Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers (Business Wire)
Nov-07-24 04:05PM	Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-05-24 04:05PM	Pulmonx to Present at the Stifel 2024 Healthcare Conference (GlobeNewswire) +8.44%
09:55AM	Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know (Zacks)
Oct-31-24 07:00AM	Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... (GuruFocus.com) -7.95%
Oct-30-24 06:25PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-16-24 04:05PM	Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024 (GlobeNewswire) -5.74%
Sep-09-24 04:05PM	Pulmonx Announces Presentation of Clinical Data from the AeriSeal CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 (GlobeNewswire) +9.00%
Aug-29-24 04:05PM	Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference (GlobeNewswire)
Aug-22-24 04:05PM	Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference (GlobeNewswire) +9.32%
Jul-31-24 05:50PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.08%
04:05PM	Pulmonx Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-29-24 04:05PM	Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire) -9.16%
Jul-10-24 04:05PM	Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024 (GlobeNewswire) +13.86%
May-22-24 09:55AM	How Much Upside is Left in Pulmonx (LUNG)? Wall Street Analysts Think 80.3% (Zacks)
May-06-24 05:03PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.50%
09:55AM	Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High? (Zacks)
May-03-24 09:43AM	Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) +21.50%
07:05AM	Q1 2024 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
03:38AM	Pulmonx Corp (LUNG) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ... (GuruFocus.com)
May-01-24 08:55PM	LUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:46PM	Pulmonx Corp (LUNG) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Continued Losses (GuruFocus.com)
04:05PM	Pulmonx Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-10-24 04:05PM	Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024 (GlobeNewswire)
Apr-02-24 04:05PM	Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer (GlobeNewswire) -6.79% -6.58%
Mar-15-24 05:00PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-29-24 11:35PM	Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp (GuruFocus.com)
Feb-26-24 08:00AM	Pulmonx Announces Treatment of the First Patient with the AeriSeal System in CONVERT II Pivotal Trial (Business Wire)
Feb-22-24 09:55AM	Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript (Insider Monkey) -18.21%
06:56AM	Q4 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 04:44PM	Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses (GuruFocus.com)
04:06PM	Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
04:05PM	Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer (GlobeNewswire)
Feb-17-24 12:08AM	Insider Sell: President and CEO French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG) (GuruFocus.com)
Feb-13-24 01:08PM	PRIMECAP Management Bolsters Position in Pulmonx Corp (GuruFocus.com)
Feb-07-24 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 (GlobeNewswire)
Dec-22-23 11:19PM	Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG) (GuruFocus.com)
Dec-11-23 09:00AM	The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors (GlobeNewswire)
Nov-17-23 01:08PM	Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare (InvestorPlace)
Nov-15-23 04:05PM	Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Oct-31-23 04:05PM	Pulmonx to Participate at Upcoming Investor Conferences (GlobeNewswire) +11.41%
09:00AM	Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:03AM	Q3 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-30-23 06:30PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:53PM	Pulmonx Corp (LUNG) Reports Record Q3 2023 Financial Results (GuruFocus.com)
04:05PM	Pulmonx Reports Record Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-16-23 04:05PM	Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023 (GlobeNewswire)
Oct-10-23 04:05PM	Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue (GlobeNewswire) -13.36%
Aug-30-23 04:05PM	Pulmonx to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-02-23 05:55PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 04:05PM	Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire) +7.23%
Jul-19-23 04:05PM	Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023 (GlobeNewswire)
Jul-17-23 08:00AM	Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023 (GlobeNewswire)
Jul-10-23 08:47AM	Shareholders in Pulmonx (NASDAQ:LUNG) are in the red if they invested a year ago (Simply Wall St.)
May-03-23 10:43AM	Q1 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents) +8.63%
May-02-23 05:35PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.90%
04:05PM	Pulmonx Reports First Quarter 2023 Financial Results (GlobeNewswire)

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
STEVEN WILLIAMSON	Officer	Jan 22 '26	Proposed Sale	1.95	48,892	95,339		Jan 22 04:02 PM
STEVEN WILLIAMSON	Officer	Jan 15 '26	Proposed Sale	1.95	15,892	31,039		Jan 15 05:49 PM
STEVEN WILLIAMSON	Officer	Jan 14 '26	Proposed Sale	2.00	31,082	62,074		Jan 14 05:13 PM
Florin Daniel P	Director	Dec 08 '25	Sale	1.99	23,321	46,409	93,910	Dec 09 05:59 PM
DANIEL P FLORIN	Director	Dec 08 '25	Proposed Sale	1.99	23,321	46,385		Dec 08 06:26 PM
French Glendon E. III	President and CEO	Dec 01 '25	Sale	1.57	8,805	13,824	277,324	Dec 03 07:51 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Dec 01 '25	Sale	1.57	6,322	9,926	373,466	Dec 03 07:48 PM
Lehman David Aaron	GENERAL COUNSEL	Dec 01 '25	Sale	1.57	10,278	16,136	252,992	Dec 03 07:43 PM
Williamson Steven S.	PRESIDENT AND CEO	Sep 02 '25	Sale	1.60	9,648	15,437	358,967	Sep 03 05:14 PM
Joshi Mehul	Chief Financial Officer & PAO	Sep 02 '25	Sale	1.60	7,936	12,698	208,489	Sep 03 05:12 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Sep 02 '25	Sale	1.60	6,543	10,469	379,788	Sep 03 05:10 PM
Lehman David Aaron	GENERAL COUNSEL	Sep 02 '25	Sale	1.60	9,769	15,630	263,270	Sep 03 05:08 PM
Ferrari Richard	Director	Jun 12 '25	Sale	3.16	8,000	25,280	87,024	Jun 13 05:38 PM
Ferrari Richard	Director	Jun 13 '25	Proposed Sale	3.01	5,438	16,368		Jun 13 11:47 AM
RICH FERRARI	Director	Jun 12 '25	Proposed Sale	3.16	8,000	25,307		Jun 12 05:24 PM
Florin Daniel P	Director	Jun 05 '25	Buy	3.06	23,321	71,362	117,231	Jun 05 08:39 PM
Williamson Steven S.	PRESIDENT AND CEO	Jun 02 '25	Sale	3.13	9,923	31,059	366,115	Jun 04 06:13 PM
Joshi Mehul	Chief Financial Officer & PAO	Jun 02 '25	Sale	3.13	8,061	25,231	213,925	Jun 04 06:10 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Jun 02 '25	Sale	3.13	6,947	21,748	386,331	Jun 04 06:04 PM
Lehman David Aaron	GENERAL COUNSEL	Jun 02 '25	Sale	3.13	10,457	32,736	273,039	Jun 04 06:02 PM
French Glendon E. III	Director	Mar 20 '25	Sale	7.85	20,000	157,000	991,974	Mar 21 06:14 PM
GLENDON FRENCH	Director	Mar 20 '25	Proposed Sale	7.77	60,000	466,200		Mar 20 04:19 PM
Joshi Mehul	Chief Financial Officer & PAO	Mar 03 '25	Sale	7.12	14,384	102,414	113,986	Mar 05 06:12 PM
Williamson Steven S.	PRESIDENT AND CEO	Mar 03 '25	Sale	7.14	27,689	197,699	194,342	Mar 05 06:09 PM
Lehman David Aaron	GENERAL COUNSEL	Mar 03 '25	Sale	7.65	22,355	170,921	175,496	Mar 05 06:04 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Mar 03 '25	Sale	7.13	5,779	41,193	285,278	Mar 05 06:02 PM
DAVID LEHMAN	Officer	Mar 03 '25	Proposed Sale	7.97	13,622	108,569		Mar 03 04:44 PM
French Glendon E. III	Director	Feb 20 '25	Sale	8.28	55,453	459,086	1,011,974	Feb 24 05:50 PM
GLENDON FRENCH	Officer	Feb 20 '25	Proposed Sale	6.64	55,453	368,208		Feb 20 04:22 PM

INSP

Inspire Medical Systems Inc

LUNG

Pulmonx Corp

Upgrade your FINVIZ experience